Search research articles
Contact Us
Filters
Showing results (1-10 of 29) with videos related to
Page
of 3
Sort By:
Joint Bone Spine
|
February 26, 2023
Predicting the onset of rheumatoid arthritis
Benoît Thomas P Gilbert, Céline Lamacchia
Nature Reviews. Rheumatology
|
February 24, 2010
IL-1 pathways in inflammation and human diseases
Cem Gabay, Céline Lamacchia, Gaby Palmer
Cytokine
|
May 21, 2013
Endogenous IL-1α is a chromatin-associated protein in mouse macrophages
Céline Lamacchia, Emiliana Rodriguez, Gaby Palmer, et al.
The Journal of Biological Chemistry
|
May 26, 2009
Interleukin-33 is biologically active independently of caspase-1 cleavage
Dominique Talabot-Ayer, Céline Lamacchia, Cem Gabay, et al.
Arthritis and Rheumatism
|
January 30, 2010
Enhanced Th1 and Th17 responses and arthritis severity in mice with a deficiency of myeloid cell-specific interleukin-1 receptor antagonist
Céline Lamacchia, Gaby Palmer, Christian A Seemayer, et al.
Journal of Leukocyte Biology
|
October 21, 2011
The mouse interleukin (Il)33 gene is expressed in a cell type- and stimulus-dependent manner from two alternative promoters
Dominique Talabot-Ayer, Nicolas Calo, Solenne Vigne, et al.
Journal of Immunology (Baltimore, Md. : 1950)
|
July 20, 2010
Distinct roles of hepatocyte- and myeloid cell-derived IL-1 receptor antagonist during endotoxemia and sterile inflammation in mice
Céline Lamacchia, Gaby Palmer, Loraine Bischoff, et al.
Frontiers in Immunology
|
March 6, 2023
Brief report: Assessment of mucosal barrier integrity using serological biomarkers in preclinical stages of rheumatoid arthritis
Benoît Thomas P Gilbert, Céline Lamacchia, Lena Amend, et al.
European Journal of Immunology
|
April 28, 2012
Mice deficient in hepatocyte-specific IL-1Ra show delayed resolution of concanavalin A-induced hepatitis
Céline Lamacchia, Emiliana Rodriguez, Gaby Palmer, et al.
Arthritis and Rheumatism
|
April 18, 2012
Long-term amelioration of established collagen-induced arthritis achieved with short-term therapy combining anti-CD3 and anti-tumor necrosis factor treatments
Fabien Dépis, Eric Hatterer, Céline Lamacchia, et al.
Page
of 3
Search research articles
Search
Showing results (1-10 of 29) with videos related to
Sort By:
Page
of 3
Joint Bone Spine
|
February 26, 2023
Predicting the onset of rheumatoid arthritis
Benoît Thomas P Gilbert, Céline Lamacchia
Nature Reviews. Rheumatology
|
February 24, 2010
IL-1 pathways in inflammation and human diseases
Cem Gabay, Céline Lamacchia, Gaby Palmer
Cytokine
|
May 21, 2013
Endogenous IL-1α is a chromatin-associated protein in mouse macrophages
Céline Lamacchia, Emiliana Rodriguez, Gaby Palmer, et al.
The Journal of Biological Chemistry
|
May 26, 2009
Interleukin-33 is biologically active independently of caspase-1 cleavage
Dominique Talabot-Ayer, Céline Lamacchia, Cem Gabay, et al.
Arthritis and Rheumatism
|
January 30, 2010
Enhanced Th1 and Th17 responses and arthritis severity in mice with a deficiency of myeloid cell-specific interleukin-1 receptor antagonist
Céline Lamacchia, Gaby Palmer, Christian A Seemayer, et al.
Journal of Leukocyte Biology
|
October 21, 2011
The mouse interleukin (Il)33 gene is expressed in a cell type- and stimulus-dependent manner from two alternative promoters
Dominique Talabot-Ayer, Nicolas Calo, Solenne Vigne, et al.
Journal of Immunology (Baltimore, Md. : 1950)
|
July 20, 2010
Distinct roles of hepatocyte- and myeloid cell-derived IL-1 receptor antagonist during endotoxemia and sterile inflammation in mice
Céline Lamacchia, Gaby Palmer, Loraine Bischoff, et al.
Frontiers in Immunology
|
March 6, 2023
Brief report: Assessment of mucosal barrier integrity using serological biomarkers in preclinical stages of rheumatoid arthritis
Benoît Thomas P Gilbert, Céline Lamacchia, Lena Amend, et al.
European Journal of Immunology
|
April 28, 2012
Mice deficient in hepatocyte-specific IL-1Ra show delayed resolution of concanavalin A-induced hepatitis
Céline Lamacchia, Emiliana Rodriguez, Gaby Palmer, et al.
Arthritis and Rheumatism
|
April 18, 2012
Long-term amelioration of established collagen-induced arthritis achieved with short-term therapy combining anti-CD3 and anti-tumor necrosis factor treatments
Fabien Dépis, Eric Hatterer, Céline Lamacchia, et al.
Page
of 3